ANDA 40909, held by Citrusphrma. Sodium Polystyrene Sulfonate.
As of Nov 15, 2026, ANDA 40909 (Sodium Polystyrene Sulfonate), held by Citrusphrma, was first approved by FDA on Dec 3, 2008, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 3, 2008 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Sodium Polystyrene Sulfonate454GM/BOT ยท powder;oral, rectal | Sodium Polystyrene Sulfonate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
